Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, Pipeleers D, Ling Z, and Drucker DJ
Special Precautions Administration of high doses of the oral formulations of levocarnitine for long periods of time is not recommended in patients with severely compromised renal function or in ESRD patients on dialysis due to the fact that major metabolites formed following oral administration trimethylamine (TMA) and trimethylamine-N-oxide (TMAO) will accumulate since they can not be efficiently removed by the kidneys
In each of the three cases, the mean steady-state plasma concentration is 10 mg/L
Alongside our research team, my co-intern, Dana Garibaldi, and I worked on a scoping review that looked at the commercialization of digital menopause products
Do not use if seal or package is broken
10.1001/jama.296.1.87